We provide integrated services across:
Apr 11, 2025
What technology areas can we support?
We provide integrated services across:
- Autologous and allogeneic cell therapies (e.g. T cells, iPSCs, MSCs)
- Viral vectors (e.g. AAV, lentivirus, including scalable suspension processes)
- RNA technologies (e.g. mRNA, saRNA, cRNA with LNP encapsulation) We support process development, tech transfer, GMP manufacturing, and fill finish for these modalities within a single site.
Latest News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services to offer end-to-end support for cell therapy developers
Sep 2, 2025
Industry News
Rethinking iPSC Development: Why Adopting an Early CMC Strategy is Essential
Aug 13, 2025
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.